ArticleHepatology communications2017

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.

Tadashi Namisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.